Location: United States, Remote
Diviner is seeking a senior biotech analyst with experience in science, medicine, and finance, to study pharmaceutical clinical trials – especially their biomedical aspects – and provide the basis for the group’s evaluation of the trials and prediction of their probabilities of success.
You have excelled as a biotech analyst for a content provider or analyst firm or will have actively worked in a biopharma company in a position with exposure to many clinical trials. You have a passion for biomedical and/or pharma research, successfully assessing diverse drugs. You dig through public literature and data for hidden gems or flaws, compiling summaries of biotech companies, including their management teams, the drugs they have in development, their biomedical aspects, clinical & regulatory considerations, market potential, and the details & data of ongoing trials. You work well in a team, and are very effective doing independent research.
This is a fully remote position. Candidates can be based in any time zone within six hours of US EST. However, the candidate must be compatible with core meetings on US Eastern time, including Mondays from 3-3:30 pm and Wednesdays 1-2 pm (ET). Otherwise, the position is approximately 16 hours over a two week cycle, with substantial flexibility on timing of work hours. The opportunity is expected to expand as Diviner scales up its operations.
Commensurate with experience and ability. Includes both base pay and stock options.
Diviner is a unique startup applying human-centered prediction science to forecast drug development outcomes and their impact on stock prices.
Diviner is committed to hiring and retaining a diverse workforce. We are proud to be an Equal Opportunity/Affirmative Action-Employer, making decisions without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability status, age, marital status, protected veteran status or any other protected class.
Your application information will be kept confidential according to EEO guidelines.